- Represented Global Payments on its $2 billion offering of convertible senior notes.
- Counsel to DEUTZ Corporation in its acquisition of Blue Star Power Systems.
- Advising public companies and their boards of directors on strategic decisions, risk oversight, governance, and SEC disclosures.
- Advising companies on securities offerings of equity and debt, including numerous initial public offerings.
- Counsel to one of the U.S.’s largest small-loan consumer finance companies in a $300 million 144A senior notes offering.
- Counsel to multiple biopharmaceutical clients in various stages of development.
- Counsel to multiple special purpose acquisition companies, including representation throughout the de-SPAC process.
- Counsel to a U.S. subsidiary of a global renewable energy project owner and operator in the financing and development of several solar energy projects across the U.S.
- Represented a biopharmaceutical startup in a reverse merger in conjunction with private placement of common stock.
- Assisted a Netherlands-based floricultural company with its acquisition of a U.S.-based horticultural company.
- Counsel to a development-stage biotech company in its two-step sale transaction to a global generic pharmaceutical company.
Senior Associate,
- Phone: +1 212 210 9470
- Email: robyn.downing@alston.com
Clients value Robyn’s strategic input on various securities compliance and corporate governance matters, as well as her critical guidance through foreign and domestic mergers and acquisitions.
- Represented the financial advisors of Charter Communications in its $17.9 billion acquisition of Liberty Broadband Corporation.
- Represented the financial advisors to Altair Engineering in its $10.6 billion sale to Siemens.
- Represented the financial advisors of Worldpay in its acquisition by Fidelity National Information Services in a $43 billion cash and stock transaction.
- Represented the financial advisors of Hormel Foods in its $3.35 billion acquisition of Planters snack nut portfolio from Kraft Heinz.
- Represented the financial advisors of Hexion in its $2 billion sale to private equity firm American Securities.
- Represented the financial advisors of Independence Energy in its $5.7 billion business combination with Contango Oil & Gas.
- Represented the financial advisors of Diamond S Shipping Inc. in its $416 million merger with International Seaways.
Robyn Downing advises public and private companies on corporate governance matters, public offerings, capital structuring, and securities regulation and compliance. Robyn counsels institutional clients in domestic and cross-border M&A and corporate finance transactions across a wide range of industries. She also advises investment banks and financial advisors in M&A transactions.
Before joining the firm, Robyn interned with the U.S. Securities and Exchange Commission’s enforcement division, where she gained valuable insight into how the agency conducts investigations. In 2021, Robyn was selected as an inaugural winner of the Rising Star award at Pace University’s Elisabeth Haub School of Law.
-
Press Release December 14, 2022Larkspur Health Acquisition Corp. Combines with ZyVersa TherapeuticsAlston & Bird client Larkspur Health Acquisition Corp., a blank-check special purpose acquisition company, has completed its business combination with ZyVersa Therapeutics Inc., a clinical stage specialty biopharmaceutical company, in a transaction valued at $108.92 million.Press Release December 14, 2022Larkspur Health Acquisition Corp. Combines with ZyVersa TherapeuticsAlston & Bird client Larkspur Health Acquisition Corp., a blank-check special purpose acquisition company, has completed its business combination with ZyVersa Therapeutics Inc., a clinical stage specialty biopharmaceutical company, in a transaction valued at $108.92 million.
-
Press Release February 8, 2022Nuvectis Pharma Closes $16 Million Initial Public Offering of Common StockAlston & Bird client Nuvectis Pharma Inc., an oncology-focused biopharmaceutical company based in Fort Lee, NJ, has announced the closing of its initial public offering (IPO) of 3.2 million shares of common stock at a price of $5 per share, for gross proceeds of $16 million before deducting underwriting discounts and offering expenses. All shares of common stock were offered by Nuvectis.Press Release February 8, 2022Nuvectis Pharma Closes $16 Million Initial Public Offering of Common StockAlston & Bird client Nuvectis Pharma Inc., an oncology-focused biopharmaceutical company based in Fort Lee, NJ, has announced the closing of its initial public offering (IPO) of 3.2 million shares of common stock at a price of $5 per share, for gross proceeds of $16 million before deducting underwriting discounts and offering expenses. All shares of common stock were offered by Nuvectis.
-
Press Release October 15, 2021World Acceptance Corporation Closes Debut $300 Million Senior Notes Offering Due 2026Alston & Bird client World Acceptance Corporation has closed its debut offering of $300 million in senior high-yield bonds.Press Release October 15, 2021World Acceptance Corporation Closes Debut $300 Million Senior Notes Offering Due 2026Alston & Bird client World Acceptance Corporation has closed its debut offering of $300 million in senior high-yield bonds.
-
Press Release March 29, 2021Robyn Downing Recognized with Inaugural “Haub Law Rising Star Award” by Pace UniversityRobyn Downing, associate in Alston & Bird’s Corporate & Business Transactions Group, has been honored by Pace University with its inaugural “Haub Law Rising Star Award” for her demonstrated passion and success in the practice of law.Press Release March 29, 2021Robyn Downing Recognized with Inaugural “Haub Law Rising Star Award” by Pace UniversityRobyn Downing, associate in Alston & Bird’s Corporate & Business Transactions Group, has been honored by Pace University with its inaugural “Haub Law Rising Star Award” for her demonstrated passion and success in the practice of law.
-
Press Release February 25, 2021Alston & Bird Ranked No. 6 Among Counsel to Investment Banks in 2020Corporate Control Alert, the legal and financial dealmaking journal published by The Deal, has ranked Alston & Bird sixth among counsel to financial advisors on U.S. M&A transactions with a value of $100 million or more announced between Jan. 1 and Dec. 31, 2020.Press Release February 25, 2021Alston & Bird Ranked No. 6 Among Counsel to Investment Banks in 2020Corporate Control Alert, the legal and financial dealmaking journal published by The Deal, has ranked Alston & Bird sixth among counsel to financial advisors on U.S. M&A transactions with a value of $100 million or more announced between Jan. 1 and Dec. 31, 2020.
-
Press Release February 23, 2021Hormel Foods to Acquire Planters Nuts Business from Kraft Heinz for $3.35 BillionAlston & Bird is acting as counsel to Citi and Credit Suisse in their roles as financial advisors to Hormel Foods in its announced $3.35 billion acquisition of the Planters snack nut portfolio from Kraft Heinz.Press Release February 23, 2021Hormel Foods to Acquire Planters Nuts Business from Kraft Heinz for $3.35 BillionAlston & Bird is acting as counsel to Citi and Credit Suisse in their roles as financial advisors to Hormel Foods in its announced $3.35 billion acquisition of the Planters snack nut portfolio from Kraft Heinz.
-
In the News February 11, 2021Law360 | Faegre, Gibson Shepherd $3.35B Deal for Planters Nuts BizStuart Rogers and Robyn Downing are noted for representing Citi Bank and Credit Suisse in their roles as financial advisors to Hormel Foods in its proposed $3.35 billion acquisition of the Planters snack nut portfolio from Kraft Heinz.In the News February 11, 2021Law360 | Faegre, Gibson Shepherd $3.35B Deal for Planters Nuts BizStuart Rogers and Robyn Downing are noted for representing Citi Bank and Credit Suisse in their roles as financial advisors to Hormel Foods in its proposed $3.35 billion acquisition of the Planters snack nut portfolio from Kraft Heinz.
-
In the News February 3, 2021Global Legal Chronicle | OncoSec Medical’s $42 Million Shares OfferingMatt Mamak, Robyn Downing, Laura Giambalvo, Bryan Skelton, and Kirk Ekena are noted for representing OncoSec Medical Incorporated in a $42 million public offering of common stock.In the News February 3, 2021Global Legal Chronicle | OncoSec Medical’s $42 Million Shares OfferingMatt Mamak, Robyn Downing, Laura Giambalvo, Bryan Skelton, and Kirk Ekena are noted for representing OncoSec Medical Incorporated in a $42 million public offering of common stock.
-
Press Release February 1, 2021OncoSec Medical Closes $42 Million Public Offering of Common StockAlston & Bird client OncoSec Medical Incorporated, a late-stage biotechnology company, has closed a public offering of common stock that raised approximately $42 million.Press Release February 1, 2021OncoSec Medical Closes $42 Million Public Offering of Common StockAlston & Bird client OncoSec Medical Incorporated, a late-stage biotechnology company, has closed a public offering of common stock that raised approximately $42 million.
-
In the News August 6, 2020Law360 | 5 Firms Assist Intercontinental Exchange’s $11B Ellie Mae BuyStuart Rogers, Kevin Miller, and Robyn Downing are noted for representing Credit Suisse as financial adviser to Intercontinental Exchange.In the News August 6, 2020Law360 | 5 Firms Assist Intercontinental Exchange’s $11B Ellie Mae BuyStuart Rogers, Kevin Miller, and Robyn Downing are noted for representing Credit Suisse as financial adviser to Intercontinental Exchange.
Bar Admissions
- New York
Education
- Pace University (J.D., 2017)
- Marist College (B.S., 2014)
Memberships
- Family Legal Care, Lawyers Council
- Youth About Business, local advisory board